Volume 11, Issue 4 (Scientific Journal of Hamadan University of Medical Sciences-Winter 2005)                   Avicenna J Clin Med 2005, 11(4): 60-62 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Gholyaf M, Abbasi M, Khoshjoo F. A Case Report of Membranous Nephropathy and Malignancy. Avicenna J Clin Med 2005; 11 (4) :60-62
URL: http://sjh.umsha.ac.ir/article-1-594-en.html
Abstract:   (6350 Views)

Malignancy is observed in 5-10% of MN in adults , with the risk being highest in patients over the age of 60. A Solid tumor (such as carcinoma of the lung or colon) is most often involved. It is presumed that tumor antigens are deposited in the glomeruli : this is followed by antibody deposition and complement activation , leading to epithelial cell and basement membrane injury and proteinuria due to the associated increase in glomerular permeability. These processes are reversed with removal of the
   tumor , usually leading to gradual remission of the proteinuria.

The malignancy in presumed tumor-induced MN has usually been diagnosed or is clinically apparent at the time at which the proteinuria is noted. The incidence of occult tumor causing MN is less than one to two percent. As a results , a tumor work-up should not be initiated in the absences of some suggestive finding such as unexplained anemia , guaiac positive stools , or weight loss.

The presented patient was a 76 years old man and he was suffering from MN. In the followed studies , the existence of metastatic malignancy was proved.

Full-Text [PDF 155 kb]   (6441 Downloads)    
Type of Study: Case Report | Subject: Other Clinical Specialties

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Avicenna Journal of Clinical Medicine

Designed & Developed by : Yektaweb